Aquasomes: a promising carrier for peptides and protein delivery

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 6, Issue 3, 2010, Pages 419-426

  Umashankar, Marakanam S ^a   Sachdeva, Rajesh K ^a   Gulati, Monica ^a  

^a LOVELY PROFESSIONAL UNIVERSITY   (India)

Author keywords

Aquasome; Ceramic; Enzyme; Nanoparticles; Peptide delivery

Indexed keywords

ACTIVE MOLECULES; AQUASOME; BIOACTIVE MOLECULES; CARBOHYDRATE COATINGS; CARRIER SYSTEMS; CONFORMATIONAL INTEGRITY; DELIVERY SYSTEMS; NANO PARTICULATES; NANOCRYSTALLINE CORES; ORAL DELIVERY; PEPTIDE DELIVERY; PROTEIN CARRIER; PROTEIN DELIVERY; SELF ASSEMBLED STRUCTURES; SOLID CORE; STRUCTURAL PROTEINS; STRUCTURAL STABILITIES; TROUBLESHOOTS;

ANTIGENS; CARBOHYDRATES; CATALYSTS; CERAMIC MATERIALS; ENZYMES; MOLECULES; NANOPARTICLES; OLIGOMERS; STABILITY;

PEPTIDES;

ALPHA INTERFERON; ALUMINUM POTASSIUM SULFATE; AQUASOME; CALCIUM PHOSPHATE; CELLOBIOSE; HEMOGLOBIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HYDROXYAPATITE; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; IMMUNOLOGICAL ADJUVANT; INDOMETACIN; INSULIN; MALARIA VACCINE; MANNITOL; MEROZOITE SURFACE PROTEIN 119; NANOCARRIER; NANOCERAMIC; RECOMBINANT HUMAN SERUM ALBUMIN; RECOMBINANT PROTEIN; SERRATIOPEPTIDASE; SUCROSE; TREHALOSE; UNCLASSIFIED DRUG; DRUG CARRIER; PEPTIDE; PROTEIN; WATER;

ADJUVANT THERAPY; ADSORPTION; ANTIBODY RESPONSE; CELLULAR IMMUNITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; FREEZE DRYING; GLASS TRANSITION TEMPERATURE; HERPES SIMPLEX VIRUS 2; IMMUNIZATION; INSULIN TREATMENT; NANOBIOTECHNOLOGY; NANOFABRICATION; NONHUMAN; OXYGEN AFFINITY; PARTICLE SIZE; PROTEIN DENATURATION; PROTEIN INTERACTION; PROTEIN STABILITY; REVIEW; SLOW DRUG RELEASE; SPRAY DRYING; TRANSITION TEMPERATURE; X RAY DIFFRACTION; ANIMAL; CHEMISTRY; HUMAN;

ANIMALS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; PEPTIDES; PROTEINS; WATER;

EID: 77952744795     PISSN: 15499634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nano.2009.11.002     Document Type: Review

References (53)

1. Juliano R.L. Microparticulate drug carriers: liposomes, microspheres and cells. In: Robinson J.R., and Lee V.H.L. (Eds). Controlled drug delivery. 2nd ed (2005), Marcel Dekker, Inc., New York 555-580
2. Rawat M., Singh D., Saraf S., and Saraf S. Nanocarriers: promising vehicles for bioactive drugs. Biol Pharm Bull 29 (2006) 1790-1798
3. Degim I.T., and Celebi N. Controlled delivery of peptides and proteins. Curr Pharm Des 13 (2007) 99-117
4. Veuillez F., Kalia Y.N., Jacques Y., Deshusses J., and Buri P. Factors and strategies for improving buccal absorption of peptides. Eur J Pharm Biopharm 51 (2001) 93-109
5. Pontiroli A.E. Intranasal administration of calcitonin and of other peptides: studies with different promoters. J Control Release 13 (1990) 247-251
6. Mackay M., Phillips J., and Hastewell J. Peptide drug delivery: colonic and rectal absorption. Adv Drug Deliv Rev 28 (1997) 253-273
7. Smith P.L. Peptide delivery via the pulmonary route: a valid approach for local and systemic delivery. J Control Release 46 (1997) 99-106
8. Lee V.H. Enzymatic barriers to peptide and protein absorption. Crit Rev Ther Drug Carrier Sys 5 (1988) 69-97
9. Mingda B., and Singh J. Degradation of luteinizing hormone releasing hormone in buccal, liver, nasal and skin tissues. Int J Pharm 175 (1998) 269-273
10. Al-Tahami K., and Singh J. Smart polymer based delivery systems for peptides and proteins. Recent Pat Drug Deliv Formul 1 (2007) 65-71
11. Prausnitz M.R. Microneedles for transdermal drug delivery. Adv Drug Deliv Rev 56 (2004) 581-587
12. Pillai O., Nair V., and Panchagnula R. Transdermal iontophoresis of insulin: influence of chemical enhancers. Int J Pharm 269 (2004) 109-120
13. Chien Y.W. Novel drug delivery systems. 2nd ed. (2007), Marcel Dekker, Inc., New York 631-647
14. Vyas S.P., and Khar R.K. Introduction to parenteral drug delivery. In: Vyas S.P., and Khar R.K. (Eds). Targeted and controlled drug delivery (2002), CBS Publishers & Distributors, New Delhi 3-37
15. Kossovsky N., Gelman A., Rajguru S., Nguyan R., Sponsler E., Hnatyszyn C.K., et al. Control of molecular polymorphism by a structured carbohydrate/ceramic delivery vehicle-aquasomes. J Control Release 39 (1996) 383-388
16. Luo D., Han E., Belcheva N., and Saltzman W.M. A self-assembled, modular delivery system mediated by silica nanoparticles. J Control Release 95 (2004) 333-341
17. Kaushik J.K., and Bhat R. Why is trehalose an exceptional protein stabilizer?. J Biol Chem 278 (2003) 26458-26465
18. Arakawa T., and Timsheff S.N. Stabilization of protein structures by sugars. Biochemistry 21 (1992) 6536-6544
19. Han Y., Jin B., Lee S., Sohn Y., Joung J., and Lee J. Effects of sugar additives on protein stability of recombinant human serum albumin during lyophilization and storage. Arch Pharm Res 30 (2007) 1124-1131
20. Jain N.K., and Umamaheshwari R.B. Control and novel drug delivery systems. In: Jain N.K. (Ed). Pharmaceutical product development (2006), CBS Publishers & Distributors, New Delhi 419-455
21. Cherian A.K., Rana A.C., and Jain S.K. Self-assembled carbohydrate-stabilized ceramic nanoparticles for the parenteral delivery of insulin. Drug Dev Ind Pharm 26 (2000) 459-463
22. Oviedo R.I., Lopez S.A.D., Gasga R.J., and Barreda C.T.Q. Elaboration and structural analysis of aquasomes loaded with indomethecin. Eur J Pharm Sci 32 (2007) 223-230
23. Vyas S.P., Goyal A.K., Khatri K., Mishra N., Mehta A., Vaidya B., et al. Aquasomes-a nanoparticulate approach for the delivery of antigen. Drug Dev Ind Pharm 34 (2008) 1297-1305
24. Khopade A.J., Khopade S., and Jain N.K. Development of haemoglobin aquasomes from spherical hydroxyapatite cores precipitated in the presence of poly(amidoamine) dendrimer. Drug Dev Ind Pharm 241 (2002) 145-154
25. Vyas S.P., Goyal A.K., Rawat A., Mahor S., Gupta P.N., and Khatri K. Nanodecoy system: a novel approach to design hepatitis B vaccine for immunopotentiation. Int J Pharm 309 (2006) 227-233
26. Paul W., and Sharma C.P. Porous hydroxyapatite nanoparticles for intestinal delivery of insulin. Trends Biomater Artif Organs 14 (2001) 37-38
27. Rawat M., Singh D., Saraf S., and Saraf S. Development and in vitro evaluation of alginate gel-encapsulated, chitosan-coated ceramic nanocores for oral delivery of enzyme. Drug Dev Ind Pharm 34 (2008) 181-188
28. Patil S., Pancholli S.S., Agrawal S., and Agrawal G.P. Surface-modified mesoporous ceramics as delivery vehicle for haemoglobin. Drug Deliv 11 (2004) 193-199
29. Kossovsky N., Gelman A., Hnatyszyn H.J., Rajguru S., Garrell L.R., Torbati S., et al. Surface-modified diamond nanoparticles as antigen delivery vehicles. Bioconjug Chem 6 (1995) 507-510
30. Goyal A.K., Khatri K., Mishra N., Mehta A., Vaidya B., Tiwari S., et al. Development of self-assembled nanoceramic carrier construct(s) for vaccine delivery. J Biomater Appl 24 (2009) 65-84
31. He Q., Mitchell A.R., Johnson S.T., Wagner-Bartak C., Morcol T., and Bell S.J.D. Calcium phosphate nanoparticle adjuvant. Clin Diagn Lab Immunol 7 (2000) 899-903
32. Mizushima Y., Ikoma T., Tanaka J., Hoshi K., Ishihara T., Ogawa Y., et al. Injectable porous hydroxyapatite microparticles as a new carrier for protein and lipophilic drugs. J Control Rel 110 (2006) 260-265
33. Medicine in development biotechnology pharmaceutical research and manufacturers of America, 2006 Washington, DC, 2006, August.
34. Cape S.P., Villa J.A., Huang E.T.S., Yang T.H., Carpenter J.F., and Sievers R.E. Preparation of active proteins, vaccines and pharmaceuticals as fine powders using supercritical or near-critical fluids. Pharm Res 25 (2008) 1967-1990
35. Benjamin C., Eric E., William E., Sidney M., Mary A.H., Ming L., et al. Enhancing skin wound healing by direct intracellular ATP delivery. Am J Surg 193 (2007) 213-218
36. Wei Z., Janak P., Daniel J.U., Ajit J., Ozlem G.A., Anton S., et al. Three classes of glucocerebrosidase inhibitors identified by quantitative high-throughput screening are chaperone leads for Gaucher disease. Proc Natl Acad Sci U S A 104 (2007) 13192-13197
37. Reddy M.K., Wu L., Kou W., Ghorpade A., and Labhasetwar V. Superoxide dismutase-loaded PLGA nanoparticles protect cultured human neurons under oxidative stress. Appl Biochem Biotechnol 151 (2008) 565-577
38. Visaria R.K., Griffin R.J., Williams B.W., Ebbini E.S., Paciotti G.F., Song C.W., et al. Enhancement of tumor thermal therapy using gold nanoparticle-assisted tumor necrosis factor-A delivery. Mol Cancer Ther 5 (2006) 1014-1020
39. Krishnan L., Sad S., Patel G.B., and Sprott G.D. The potent adjuvant activity of archaeosomes correlates to the recruitment and activation of macrophages and dendritic cells in-vivo. J Immunol 166 (2001) 1885-1893
40. Cevc G.G. Drug-carrier and stability properties of the long-lived lipid vesicles cryptosomes, in vitro and in vivo. J Liposome Res 2 (1992) 355-368
41. Arora R., and Jain C.P. Advances in niosome as a drug carrier: a review. Asian J Pharm 1 (2007) 29-39
42. Vyas S.P., Rasika S., and Jain S. Development and characterization of emulsomes for sustained and targeted delivery of an antiviral agent to liver. J Pharm Pharmacol 58 (2006) 321-326
43. Vyas S.P., Khatri K., and Goyal A.K. Functionalized nanocarrier(s) to image and target fungi infected immune cells. Med Mycol 47 (2009) S362-368
44. Gaspar M.M., Boerman O.C., Laverman P., Corvo M.L., Storm G., and Cruz M.E.M. Enzymosomes with surface-exposed superoxide dismutase: in vivo behaviour and therapeutic activity in a model of adjuvant arthritis. J Control Rel 117 (2007) 186-195
45. Cuppoletti J., Mayhewt E., Zobel C.R., and Jung C.Y. Erythrosomes: large proteoliposomes derived from crosslinked human erythrocyte cytoskeletons and exogenous lipid. Proc Natl Acad Sci Biochem 78 (1981) 2786-2790
46. Patel S. Ethosomes: a promising tool for transdermal delivery of drug. Latest Rev [serial on the Internet]. 2007;5(2): [about 4 p.]. Available from: http://www.pharmainfo.net/reviews/ethosomes-promising-tool-transdermal-delivery-drug.
47. Lasic D.D., and Templeton N.S. Liposomes in gene therapy. Adv Drug Deliv Rev 20 (1996) 221-266
48. Singh P., Sihorkar V., Jaitely V., Kanaujia P., and Vyas S.P. Pilosebaceous unit: anatomical considerations and drug delivery opportunities. Ind J Pharmacol 32 (2000) 269-281
49. Vink A.A., Moodycliffe A.M., Shreedhar V., Ullrich S.E., Roza L., Yarosh D.B., et al. The inhibition of antigen-presenting activity of dendritic cells resulting from UV irradiation of murine skin is restored by in vitro photorepair of cyclobutane pyrimidine dimmers. Proc Natl Acad Sci Immunol 94 (1997) 5255-5260
50. Lowell G.H., Smith L.F., Seid R.C., and Zollinger W.D. Peptides bound to proteosomes via hydrophobic feet become highly immunogenic without adjuvants: brief definitive report. J Exp Med 167 (1988) 658-663
51. Jain S., Mishra D., Kuksal A., Tiwary A.K., and Jain N.K. Vesicular approach for drug delivery into or across the skin: current status and future prospects. Available from:. http://priory.com/pharmol/Manuscript-Jain.htm
52. Wong B., Schmidt J., and Zasadzinski J. Studying the in-vivo behavior of the vesosome. Biophys J 96 (2009) 451a-452a
53. Schwaninger R., Waelti E., Zajac P., Wetterwald A., Mueller D., and Gimmi C.D. Virosomes as new carrier system for cancer vaccines. Cancer Immunol Immunother 53 (2004) 1005-1017